This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
This protocol is to ensure standardisation of definitions, data collection and reporting procedures for hospitals participating in the national/regional surveillance of healthcare-associated infections in intensive care units across Europe.
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
This catalogue of available infection control and hospital hygiene courses (IC/HH) provides the first list of evaluated training programmes in IC/HH in EU, EEA and EU enlargement countries.
Version 5.3 is the final protocol for the second EU-wide point prevalence survey (PPS 2016–2017). It contains major changes compared to protocol version 4.3 (PPS 2011–2012). Compared to versions 5.1 (January 2016) and 5.2 (May 2016), the current version only contains a few corrections, editorial changes and clarifications.
This document is intended for hospital staff that use HelicsWin.Net to collect or administer data collected using ECDC’s HAI-Net surveillance of healthcare-associated infections methods (HAINet PPS and ICU).
This protocol provides national survey coordinators (NSCs) and national/regional validation teams (VTs) with the methodology, data collection forms and definitions of variables to collect data during the HALT-3 project.
The aim of this document is to highlight measures that can effectively reduce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.
This protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of Clostridium difficile infections (CDIs).
This document establishes a protocol for the case detection, laboratory diagnosis and environmental testing of Mycobacterium chimaera infections which are potentially associated with heater-cooler units.